MedTrace Logo

Peri-device Leakage Closure After LAAO

NCT04590898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2022-07-22

No results posted yet for this study

Summary

The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.

Conditions

Interventions

DEVICE

Peri-device leakage closure after left atrial appendage occlusion

Peri-device leakage closure after left atrial appendage occlusion

Sponsors & Collaborators

  • Cardiovascular Center Frankfurt

    lead OTHER

Principal Investigators

  • Kerstin Piayda · University Hospital Düsseldorf and Cardio Vascular Center Frankfurt

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-27
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • United States
  • Denmark
  • Germany
  • Poland
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590898 on ClinicalTrials.gov